BGI Co-Win

Hemu Gene develops gene therapy technology to treat hemoglobin disease. With independent research and development capabilities, a reliable quality management system, and two main gene editing platforms—lentivirus and CRISPR/Cas—Hemu Gene continues to focus on the study, creation, and use of gene therapy vectors and genetic engineering technology. The company has set up additional hematopoietic stem gene therapy production lines and is actively engaged in international clinical collaboration and international registration declaration.

YZY Bio is a biotechnology company that develops anti-tumor bispecific antibodies based on breakthrough discoveries in molecular biology, enabling patients with major diseases to obtain more efficient treatment solutions.

Ab&B Biotech focuses on the research and development of innovative human vaccines and multivalent vaccines.

CANbridge Pharmaceuticals is a bio-pharmaceutical company accelerating development and commercialization of specialty healthcare products for serious and critical medical conditions in China and North Asia (Korea and Taiwan). CANbridge develops partnerships with Western bio-pharmaceutical companies with clinical-stage pharmaceutical, medical device or diagnostic products that are either unavailable in China/North Asia or address medical needs that are underserved in the region. CANbridge also licenses or obtains exclusive rights to commercialize drug and device products that are approved in their home markets for commercialization in China and North Asia.

ToloBio develops molecular diagnostics solutions for pathogen detection, disease screening, and precision medicine.

Targene Medical concentrates on the study, creation, and distribution of tools for accurate and early cancer diagnosis. It is dedicated to entire cancer diagnostic and treatment process. It provides research and development of early detection tools for one type of cancer, multiple types of cancer, and even all cancers.

F&S Pharmatech is a Nanjing-based pharmaceutical technology company. It provides pharmaceutical intermediates, contract manufacture organization(CMO) service, differentiated API, with intellectual property solutions and environmentally friendly chemical technology to customers in healthcare industry.

Cellnuo develops pharmaceutical products to help patients reduce the incidence of hypoglycemia and maintain healthier blood glucose levels, improving health outcomes for patients.